IWP
MNTA

Icon Wealth Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Icon Wealth Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-488
Closed -$10K – 793
2018
Q2 		$10K Buy
+488
New +$10.5K ﹤0.01% 700
2018
Q1 		– Sell
-462
Closed -$6K – 812
2017
Q4 		$6K Buy
+462
New +$6.25K ﹤0.01% 770

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Icon Wealth Partners's MNTA Position: Q3 2018 in Review

Icon Wealth Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2018, closing a stake of 488 shares — an estimated $10K sold.

Icon Wealth Partners first reported a position in MNTA in Q4 2017 and held it in 2 quarters. The position peaked at $10K in Q2 2018. 159 funds tracked by Wall St. Rank hold MNTA as of Q3 2018.

  • Icon Wealth Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Icon Wealth Partners sold 488 Momenta Pharmaceuticals, Inc. shares in Q3 2018, an estimated $10K.
  • Icon Wealth Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Icon Wealth Partners's Momenta Pharmaceuticals, Inc. position peaked at $10K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2018.

Based on Icon Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.